These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 9210896)

  • 21. Preoperative chemoembolization in patients with hepatocellular carcinoma undergoing liver transplantation: influence of emergent versus elective procedures on patient survival and tumor recurrence rate.
    Stockland AH; Walser EM; Paz-Fumagalli R; McKinney JM; May GR
    Cardiovasc Intervent Radiol; 2007; 30(5):888-93. PubMed ID: 17619218
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatic resection for hepatocellular carcinoma in diameter of > or = 10 cm.
    Hanazaki K; Kajikawa S; Shimozawa N; Shimada K; Hiraguri M; Koide N; Adachi W; Amano J
    Hepatogastroenterology; 2002; 49(44):518-23. PubMed ID: 11995486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimal management of hepatocellular carcinoma: challenges and opportunities.
    Lin CL; Kao JH
    J Gastroenterol Hepatol; 2010 Aug; 25(8):1336-8. PubMed ID: 20659219
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparison of resection, liver transplantation and transcatheter oily chemoembolisation in the treatment of hepatocellular carcinoma.
    Jaeck D; Bronowicki JP; Boudejma K; Bachellier P; Chone L; Nisand G; Bazin C; Pflumio F; Uhl G; Wenger JJ; Boissel P; Bigard MA; Gaucher P; Vetter D; Wolf P; Doffoel M
    Wiad Lek; 1997; 50 Suppl 1 Pt 1():413-5. PubMed ID: 9383352
    [No Abstract]   [Full Text] [Related]  

  • 25. Radiofrequency ablation combined with chemoembolization for early-stage hepatocellular carcinoma.
    Cho YK
    Radiology; 2008 Nov; 249(2):718-9; author reply 719. PubMed ID: 18936322
    [No Abstract]   [Full Text] [Related]  

  • 26. Hepatocellular carcinoma outcomes based on indicated treatment strategy.
    Rose AT; Rose DM; Pinson CW; Wright JK; Blair T; Blanke C; Delbeke D; Debelak JP; Chapman WC
    Am Surg; 1998 Dec; 64(12):1128-34; discussion 1134-5. PubMed ID: 9843330
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of hepatocellular carcinoma in New Zealand.
    Gane E; McCall J
    N Z Med J; 2000 May; 113(1109):172-5. PubMed ID: 10894345
    [No Abstract]   [Full Text] [Related]  

  • 28. Role of mesohepatectomy with or without transcatheter arterial chemoembolization for large centrally located hepatocellular carcinoma.
    Chen XP; Hu DY; Zhang ZW; Zhang BX; Chen YF; Zhang WG; Qiu FZ
    Dig Surg; 2007; 24(3):208-13. PubMed ID: 17522469
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factors predicting survival in advanced T-staged hepatocellular carcinoma patients treated with reduction hepatectomy followed by transcatheter arterial chemoembolization.
    Kobayashi A; Takahashi S; Ishii H; Konishi M; Nakagohri T; Gotohda N; Satake M; Furuse J; Kinoshita T
    Eur J Surg Oncol; 2007 Oct; 33(8):1019-24. PubMed ID: 17399939
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Response to preoperative chemoembolization correlates with outcome after liver transplantation in patients with hepatocellular carcinoma.
    Millonig G; Graziadei IW; Freund MC; Jaschke W; Stadlmann S; Ladurner R; Margreiter R; Vogel W
    Liver Transpl; 2007 Feb; 13(2):272-9. PubMed ID: 17256758
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Influence of different treatment modalities on survival of patients with two -stage resection of unresectable hepatocellular carcinoma].
    Fan J; Wu Z; Tang Z
    Zhonghua Wai Ke Za Zhi; 2001 Oct; 39(10):745-8. PubMed ID: 16201184
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Survival rates according to the Cancer of the Liver Italian Program scores of 345 hepatocellular carcinoma patients after multimodality treatments during a 10-year period in a retrospective study.
    Yamagiwa K; Shiraki K; Yamakado K; Mizuno S; Hori T; Yagi S; Hamada T; Iida T; Nakamura I; Fujii K; Usui M; Isaji S; Ito K; Tagawa S; Takeda K; Yokoi H; Noguchi T
    J Gastroenterol Hepatol; 2008 Mar; 23(3):482-90. PubMed ID: 18086115
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Surgical management of patients with hepatic carcinoma].
    Li Z
    Zhonghua Wai Ke Za Zhi; 1996 Apr; 34(4):234-7. PubMed ID: 9387690
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of newer treatment modalities on survival in patients with hepatocellular carcinoma.
    Taura N; Hamasaki K; Nakao K; Ichikawa T; Nishimura D; Goto T; Fukuta M; Kawashimo H; Fujimoto M; Kusumoto K; Motoyoshi Y; Shibata H; Eguchi K
    Clin Gastroenterol Hepatol; 2006 Sep; 4(9):1177-83. PubMed ID: 16901768
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Analysis of survival in 240 patients with unresectable primary hepatocellular carcinoma treated with hepatic artery chemo-embolization].
    Cheng L; Wang Z; Cai F
    Zhonghua Zhong Liu Za Zhi; 1996 Sep; 18(5):362-4. PubMed ID: 9387276
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of hepatocellular carcinoma in the age of liver transplantation.
    Martin AP
    Int J Surg; 2009 Aug; 7(4):324-9. PubMed ID: 19643691
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liver resection improves the survival of patients with multiple hepatocellular carcinomas.
    Ho MC; Huang GT; Tsang YM; Lee PH; Chen DS; Sheu JC; Chen CH
    Ann Surg Oncol; 2009 Apr; 16(4):848-55. PubMed ID: 19159983
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatocellular Carcinoma Progression While on Waiting List for Liver Transplantation.
    Giacomoni A; Concone G; Di Sandro S; Lauterio A; De Carlis L
    Transplantation; 2015 Sep; 99(9):e155-6. PubMed ID: 26308419
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparison of 7 staging systems for patients with hepatocellular carcinoma undergoing transarterial chemoembolization.
    Cho YK; Chung JW; Kim JK; Ahn YS; Kim MY; Park YO; Kim WT; Byun JH
    Cancer; 2008 Jan; 112(2):352-61. PubMed ID: 18008352
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of hepatectomy and transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma: necessity for prospective randomized trial.
    Yoshimi F; Nagao T; Inoue S; Kawano N; Muto T; Gunji T; Ohnishi S; Imawari M
    Hepatology; 1992 Sep; 16(3):702-6. PubMed ID: 1324216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.